alfuzosin (SL770499)

DRUG2 trials

Sponsors

Sanofi

Conditions

Benign Prostatic HypertrophyProstatic HyperplasiaUrinary Bladder NeurogenicUrinary Retention

Phase 3

Clinical Trial in Males With BPH (Enlarged Prostate)

CompletedNCT00029822

SanofiBenign Prostatic Hypertrophy, Prostatic Hyperplasia, Urinary Retention

Start: 2001-05-31End: 2005-03-31Updated: 2008-06-09

Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology

CompletedNCT00629720

SanofiUrinary Bladder Neurogenic

Start: 2006-07-31End: 2007-02-28Updated: 2009-12-15